(Total Views: 502)
Posted On: 09/20/2021 8:44:27 PM
Post# of 153988
"It's not fair!!!!!!"
EDSA's mab has good phase 2 and pps soars.
"EB05 and EB06 could ameliorate proinflammatory cascades in COVID-19 patients, thereby reducing lung injury, ventilation rates and mortality."
"EB05 dampens TLR4 signaling by blocking receptor dimerization (and subsequent intracellular signaling cascades) and has been shown to be independent of ligand type and concentration, therefore broadly blocking potentially any TLR4 ligands. EB06 binds specifically and selectively to CXCL10 and inhibits the interaction of CXCL10 with its receptor."
scroll
https://www.edesabiotech.com/technology/
EDSA's mab has good phase 2 and pps soars.
"EB05 and EB06 could ameliorate proinflammatory cascades in COVID-19 patients, thereby reducing lung injury, ventilation rates and mortality."
"EB05 dampens TLR4 signaling by blocking receptor dimerization (and subsequent intracellular signaling cascades) and has been shown to be independent of ligand type and concentration, therefore broadly blocking potentially any TLR4 ligands. EB06 binds specifically and selectively to CXCL10 and inhibits the interaction of CXCL10 with its receptor."
scroll
https://www.edesabiotech.com/technology/
(0)
(0)
